方法：选择2013-09/2015-05在我院就诊的中心性渗出性脉络膜视网膜病变(CEC)连续治疗患者98例98眼。随机分为两组，试验组给予玻璃体腔注射雷珠单抗治疗，同时给予口服复方血栓通胶囊，连续治疗3mo； 对照组仅给予口服复方血栓通胶囊治疗，所用剂量及疗程同试验组。两组患者均每月按时复查，随访时间为6mo。测量治疗前后视力、黄斑中心凹视网膜厚度及渗漏面积。

结果：LogMAR视力：两组患者术前、术后LogMAR视力比较差异有统计学意义(P<0.05)，试验组术后视力提高较对照组术后明显，差异有统计学意义(P<0.05)。OCT：比较两组黄斑中心凹视网膜厚度(central macular thickness，CMT)，试验组与对照组之间有统计学差异(P<0.05)； 试验组CMT降低的程度与对照组比较较为明显。FFA：经χ²检验，渗漏减轻程度上两组间比较差异有统计学意义(P<0.05)。

结论：雷珠单抗联合复方血栓通胶囊治疗中心性渗出性脉络膜视网膜病变可以减少血管渗漏，有效减轻黄斑水肿，缩短病程，提高视力，是目前治疗CEC安全、有效的方法。多次玻璃体腔注射雷珠单抗可使CEC患者提高的视力得到稳定。

METHODS: A total of 98 consecutive patients(98 eyes)with CEC treated in our hospital from September 2013 to May 2015 were enrolled in this study and randomly divided into 2 groups. The experimental group received intravitreal injection of ranibizumab treatment, were treated with compound Xueshuantong capsule, 3 consecutive months of treatment; the control group only treated with compound Xueshuantong capsule treatment, the same dosage and course of treatment with the experimental group. Two groups of patients were reviewed monthly, the follow-up time was 6mo. Before and after treatment, visual acuity, foveal retinal thickness and leakage area were measured.

RESULTS: Visual acuity(LogMAR): the visual acuity of the two groups before and after surgery was significantly different(P<0.05); the visual acuity of the experimental group was significantly better than that of the control group, the difference was statistically significant(P<0.05). There was significant difference between experimental group and control group on central macular thickness macular(CMT)(P<0.05), which of experimental group decreased more than that of control group. The improved leakage of the two groups was significant different by χ² test(P<0.05).

CONCLUSION: Ranibizumab combined with compound Xueshuantong capsule in the treatment of CEC can reduce vascular leakage, reduce macular edema, shorten the course, improve eyesight, which is a safe and effective method for the treatment of CEC. Multiple intravitreal injection of ranibizumab to CEC can improve the vision of patients and keep it stable.